AmbryLink is Ambry's comprehensive patient testing program that provides the confidence to identify rare-disease patients quickly and accurately.
The Arrowhead Pharmaceutical Program offers confidential genetic testing for patients who have a clinical history of severe hypertriglyceridemia. The panel tests for underlying genetic causes like Familial Chylomicronemia Syndrome (FCS) and hyperlipoproteinemia.
Orderable only by health care provider, choose here to order a kit and start the genetic testing process for your patient.
Extremely high levels of low-density lipoprotein cholesterol (LDL-C) may be a sign of homozygous familial hypercholesterolemia (HoFH). A rare condition, HoFH is often undiagnosed or misdiagnosed.
This program offers no-cost, confidential genetic testing for patients who have elevated LDL-C and meet select clinical criteria.
Danon Disease Genetic Testing Program can help provide answers for those with suspected Danon Disease for which early diagnosis is critical.
The program offers testing for patients under 40 years of age meeting select eligibility utilizing Ambry’s CardioNext testing panel.